Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis
dc.creator | Uddin M.S. | |
dc.creator | Mamun A.A. | |
dc.creator | Labu Z.K. | |
dc.creator | Hidalgo-Lanussa O. | |
dc.creator | Barreto G.E. | |
dc.creator | Ashraf G.M. | |
dc.date.accessioned | 2020-09-02T22:29:29Z | |
dc.date.accessioned | 2022-11-08T20:19:56Z | |
dc.date.available | 2020-09-02T22:29:29Z | |
dc.date.available | 2022-11-08T20:19:56Z | |
dc.date.created | 2020-09-02T22:29:29Z | |
dc.date.issued | 2019 | |
dc.identifier | 234, 6, 8094-8112 | |
dc.identifier | 00219541 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6466 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143374 | |
dc.language | en | |
dc.publisher | Wiley-Liss Inc. | |
dc.subject | Alzheimer’s disease | |
dc.subject | amyloid β | |
dc.subject | autophagy | |
dc.subject | lysosomal dysfunction | |
dc.subject | mitophagy | |
dc.subject | neurofibrillary tangles | |
dc.subject | senile plaques | |
dc.subject | amyloid beta protein | |
dc.subject | carbamazepine | |
dc.subject | dimebon | |
dc.subject | lithium | |
dc.subject | mammalian target of rapamycin | |
dc.subject | metformin | |
dc.subject | minoxidil | |
dc.subject | nicotinamide | |
dc.subject | nootropic agent | |
dc.subject | peptidomimetic agent | |
dc.subject | rapamycin | |
dc.subject | resveratrol | |
dc.subject | smer 28 | |
dc.subject | tau protein | |
dc.subject | trehalose | |
dc.subject | unclassified drug | |
dc.subject | MTOR protein, human | |
dc.subject | target of rapamycin kinase | |
dc.subject | aging | |
dc.subject | Alzheimer disease | |
dc.subject | autolysosome | |
dc.subject | autophagosome | |
dc.subject | autophagy | |
dc.subject | bioenergy | |
dc.subject | brain cortex | |
dc.subject | brain mitochondrion | |
dc.subject | cell death | |
dc.subject | central nervous system | |
dc.subject | drug effect | |
dc.subject | drug mechanism | |
dc.subject | drug targeting | |
dc.subject | gene mutation | |
dc.subject | hippocampus | |
dc.subject | homeostasis | |
dc.subject | housekeeping gene | |
dc.subject | human | |
dc.subject | lysosome | |
dc.subject | mitophagy | |
dc.subject | mTOR signaling | |
dc.subject | nerve degeneration | |
dc.subject | neurofibrillary tangle | |
dc.subject | neuropathology | |
dc.subject | nonhuman | |
dc.subject | pathogenesis | |
dc.subject | pathophysiology | |
dc.subject | priority journal | |
dc.subject | protein degradation | |
dc.subject | protein phosphorylation | |
dc.subject | Review | |
dc.subject | senile plaque | |
dc.subject | xenophagy | |
dc.subject | Alzheimer disease | |
dc.subject | autophagy | |
dc.subject | cytoplasm | |
dc.subject | genetics | |
dc.subject | metabolism | |
dc.subject | mitochondrion | |
dc.subject | pathology | |
dc.subject | signal transduction | |
dc.subject | Alzheimer Disease | |
dc.subject | Amyloid beta-Peptides | |
dc.subject | Autophagosomes | |
dc.subject | Autophagy | |
dc.subject | Cytoplasm | |
dc.subject | Humans | |
dc.subject | Mitochondria | |
dc.subject | Mitophagy | |
dc.subject | Proteolysis | |
dc.subject | Signal Transduction | |
dc.subject | TOR Serine-Threonine Kinases | |
dc.title | Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis | |
dc.type | Review |